Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0386 Transporter Info | ||||
Gene Name | SLC4A5 | ||||
Transporter Name | Electrogenic sodium bicarbonate cotransporter 4 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.09E+00 | Statistic Test | p-value:6.85E-09; Z-score:2.01E+00 | ||
Methylation in Case |
4.44E-01 (Median) | Methylation in Control | 2.12E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg14932645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:9.84E-07; Z-score:1.36E+00 | ||
Methylation in Case |
9.02E-01 (Median) | Methylation in Control | 8.32E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (ch.2.1685478R) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:3.65E-09; Z-score:-1.44E+00 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg14932645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.33E-04; Z-score:-3.99E+00 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg13459852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.13E-02; Z-score:2.42E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 6.95E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:6.42E-06; Z-score:-7.10E+00 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg14932645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.54E-06; Z-score:-1.20E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.16E-02; Z-score:-9.85E-01 | ||
Methylation in Case |
7.94E-01 (Median) | Methylation in Control | 8.67E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg17808746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.99E-02; Z-score:-8.57E-01 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg15845653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:4.85E-02; Z-score:-1.37E-01 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.67E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:1.02E-03; Z-score:-9.49E-01 | ||
Methylation in Case |
4.84E-01 (Median) | Methylation in Control | 5.46E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg26319800) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:1.32E-02; Z-score:-6.34E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.74E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A5 in breast cancer | [ 3 ] | |||
Location |
3'UTR (ch.2.1685478R) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.37E+00 | Statistic Test | p-value:1.30E-02; Z-score:-6.60E-01 | ||
Methylation in Case |
2.56E-02 (Median) | Methylation in Control | 3.51E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.55E-05; Z-score:-1.80E+00 | ||
Methylation in Case |
9.16E-01 (Median) | Methylation in Control | 9.30E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg14932645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.24E-03; Z-score:-6.59E-02 | ||
Methylation in Case |
9.36E-01 (Median) | Methylation in Control | 9.37E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:1.18E-12; Z-score:-3.07E+00 | ||
Methylation in Case |
5.05E-01 (Median) | Methylation in Control | 6.86E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:9.24E-06; Z-score:-1.29E+00 | ||
Methylation in Case |
8.12E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg15845653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.67E-07; Z-score:-2.98E+00 | ||
Methylation in Case |
8.15E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg13459852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.07E-05; Z-score:-1.39E+00 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg17808746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.21E-02; Z-score:-1.69E-01 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg26319800) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:4.01E-05; Z-score:-1.10E+00 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
3'UTR (cg19237530) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:2.49E-13; Z-score:-8.02E+00 | ||
Methylation in Case |
6.43E-01 (Median) | Methylation in Control | 8.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A5 in hepatocellular carcinoma | [ 5 ] | |||
Location |
3'UTR (ch.2.1685478R) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:1.28E-03; Z-score:-5.45E-01 | ||
Methylation in Case |
5.14E-02 (Median) | Methylation in Control | 6.30E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in HIV infection | [ 6 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.38E-03; Z-score:-9.33E-01 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg13459852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:1.06E-04; Z-score:1.10E+00 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 7.94E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg17808746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:5.27E-04; Z-score:-9.79E-01 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A5 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:7.43E-06; Z-score:-2.22E+00 | ||
Methylation in Case |
5.80E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in panic disorder | [ 7 ] | |||
Location |
5'UTR (cg00945862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:2.40E-03; Z-score:2.95E-01 | ||
Methylation in Case |
3.32E+00 (Median) | Methylation in Control | 3.22E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in panic disorder | [ 7 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:2.43E-02; Z-score:3.90E-01 | ||
Methylation in Case |
1.49E+00 (Median) | Methylation in Control | 1.29E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
5'UTR (cg14932645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:6.10E-03; Z-score:-4.55E-01 | ||
Methylation in Case |
9.27E-01 (Median) | Methylation in Control | 9.34E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS1500 (cg15845653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.73E-04; Z-score:9.51E-01 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS1500 (cg13459852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:5.78E-04; Z-score:1.18E+00 | ||
Methylation in Case |
7.62E-01 (Median) | Methylation in Control | 7.07E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg07337598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:3.07E-03; Z-score:-8.70E-01 | ||
Methylation in Case |
6.20E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg06237487) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:6.23E-03; Z-score:-4.57E-01 | ||
Methylation in Case |
8.33E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg18420266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:2.42E-02; Z-score:-6.06E-01 | ||
Methylation in Case |
9.01E-02 (Median) | Methylation in Control | 9.79E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg03816707) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.61E+00 | Statistic Test | p-value:7.51E-12; Z-score:2.09E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 3.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg16087826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:6.41E-05; Z-score:-1.43E+00 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 8.20E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg14708080) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:2.56E-03; Z-score:1.57E-01 | ||
Methylation in Case |
5.19E-02 (Median) | Methylation in Control | 4.96E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg19664229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:3.04E-03; Z-score:9.45E-01 | ||
Methylation in Case |
5.83E-01 (Median) | Methylation in Control | 5.08E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC4A5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg13473691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.66E-02; Z-score:4.89E-01 | ||
Methylation in Case |
5.25E-01 (Median) | Methylation in Control | 5.00E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg17808746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.33E-02; Z-score:-7.90E-02 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A5 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:9.53E-04; Z-score:-3.08E+00 | ||
Methylation in Case |
5.56E-01 (Median) | Methylation in Control | 6.29E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A5 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg26319800) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.82E-02; Z-score:-1.85E+00 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.